KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 176 filers reported holding KITE PHARMA INC in Q2 2016. The put-call ratio across all filers is 0.44 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $10,367,000 | +1.6% | 100,000 | -23.1% | 0.18% | -19.9% |
| Q1 2017 | $10,204,000 | -9.0% | 130,000 | -48.0% | 0.23% | -9.2% |
| Q4 2016 | $11,210,000 | -36.3% | 250,000 | -20.6% | 0.25% | -28.4% |
| Q3 2016 | $17,596,000 | +8.3% | 315,000 | -3.1% | 0.35% | +3.9% |
| Q2 2016 | $16,250,000 | -27.0% | 325,000 | -33.0% | 0.34% | -22.8% |
| Q1 2016 | $22,266,000 | -27.7% | 485,000 | -3.0% | 0.43% | -25.0% |
| Q4 2015 | $30,810,000 | +2.5% | 500,000 | -7.4% | 0.58% | -13.8% |
| Q3 2015 | $30,067,000 | +16.0% | 540,000 | +27.1% | 0.67% | -39.7% |
| Q2 2015 | $25,912,000 | +19.8% | 425,000 | +13.3% | 1.12% | +11.5% |
| Q1 2015 | $21,630,000 | +7.2% | 375,000 | +7.1% | 1.00% | +41.2% |
| Q4 2014 | $20,185,000 | +237.3% | 350,000 | +66.7% | 0.71% | +221.8% |
| Q3 2014 | $5,985,000 | – | 210,000 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|